加载中
NASDAQHealthcareMedical - Devices
最新数据
US$4.37
+US$0.18 · +4.30%
EDAP TMS S.A. operates as a holding company, with its subsidiary primarily focused on the innovation, manufacturing, and distribution of advanced, minimally invasive medical devices engineered to address urological conditions. The company's activities are organized into two principal divisions: High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS). The HIFU segment is dedicated to the creation, production, and commercialization of devices that employ HIFU technology for the precise, non-surgical elimination of certain localized tumors. In contrast, the UDS division concentrates on the entire lifecycle—from development and marketing to manufacturing and servicing—of medical instruments used for the minimally invasive diagnosis and treatment of various urological disorders, particularly urinary stones and other related clinical indications. This enterprise was founded on December 3, 1979, and its corporate headquarters are located in Vaulx-en-Velin, France.
常规交易时段
US$4.37
+US$0.18 · +4.30%
盘中时间采用ET。市场数据可能有所延迟。
EDAP TMS S.A. operates as a holding company, with its subsidiary primarily focused on the innovation, manufacturing, and distribution of advanced, minimally invasive medical devices engineered to address urological conditions. The company's activities are organized into two principal divisions: High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS). The HIFU segment is dedicated to the creation, production, and commercialization of devices that employ HIFU technology for the precise, non-surgical elimination of certain localized tumors. In contrast, the UDS division concentrates on the entire lifecycle—from development and marketing to manufacturing and servicing—of medical instruments used for the minimally invasive diagnosis and treatment of various urological disorders, particularly urinary stones and other related clinical indications. This enterprise was founded on December 3, 1979, and its corporate headquarters are located in Vaulx-en-Velin, France.
日内区间
当前US$4.37
52周区间
当前US$4.37
盘中时间采用ET。市场数据可能有所延迟。
GoAI 评分
持有
估值
47
合理估值
情绪
48
多空交织
风险
33
中等风险
动量
78
动能增强
完整 GoAI 研究
继续查看更深入的依据、催化因素和风险。
EDAP TMS S.A. operates as a holding company, with its subsidiary primarily focused on the innovation, manufacturing, and distribution of advanced, minimally invasive medical devices engineered to address urological conditions. The company's activities are organized into two principal divisions: High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS). The HIFU segment is dedicated to the creation, production, and commercialization of devices that employ HIFU technology for the precise, non-surgical elimination of certain localized tumors. In contrast, the UDS division concentrates on the entire lifecycle—from development and marketing to manufacturing and servicing—of medical instruments used for the minimally invasive diagnosis and treatment of various urological disorders, particularly urinary stones and other related clinical indications. This enterprise was founded on December 3, 1979, and its corporate headquarters are located in Vaulx-en-Velin, France.
日内区间
当前US$4.37
52周区间
当前US$4.37
盈利能力占已公布营收的百分比。
营收
营业利润
净利润
| 项目（USD） | 2025财年 | 2024财年 | 2023财年 | 2022财年 | 2021财年 |
|---|---|---|---|---|---|
| 营收 | 7074.52万 USD | 6935.26万 USD | 6532.42万 USD | 5791.71万 USD | 5208.4万 USD |
| 销货成本 | 4065.14万 USD | 4062.72万 USD | 3893.31万 USD | 3249.19万 USD | 3030.95万 USD |
| 毛利 | 3009.38万 USD | 2872.54万 USD | 2639.11万 USD | 2542.52万 USD | 2177.45万 USD |
| 研究与开发 | 1012.82万 USD | 910.03万 USD | 821.22万 USD | 604.42万 USD | 562.39万 USD |
| 销售、一般及管理费用 | 4517.43万 USD | 4257.97万 USD | 4028.24万 USD | 2473.05万 USD | 1965.87万 USD |
| 营业费用 | 5530.26万 USD | 5167.99万 USD | 4849.45万 USD | 3077.46万 USD | 2528.26万 USD |
| 利息收入 | 25.28万 USD | 86.1万 USD | 141.73万 USD | 42.46万 USD | 1.18万 USD |
| 利息支出 | 79.14万 USD | 25.53万 USD | 25.08万 USD | 17.66万 USD | 6.15万 USD |
| 折旧和摊销 | 342.66万 USD | 280.37万 USD | 208.11万 USD | 172.15万 USD | 227.06万 USD |
| 营业利润 | −2520.88万 USD | −2295.46万 USD | −2210.34万 USD | −534.95万 USD | −350.81万 USD |
| 净利润 | −2933.65万 USD | −2057.14万 USD | −2289.56万 USD | −308.25万 USD | 82.74万 USD |
公司数据更新于 2026年10月8日。
近期已公布业绩
近期已公布业绩
第三方分析师预期可能变化，并非 GoAI 建议。
平均目标
US$9.67
上涨空间 121.28%AI 生成内容及延迟市场数据仅供信息与教育用途，不构成投资建议。
